Incidence, Predictors, and Course of Hepatocellular Carcinoma Following Direct-Acting Antivirals Therapy in a Prospective Genotype-3 Predominant HCV Elimination Compensated Cirrhosis Cohort
Incidence, Predictors, and Course of Hepatocellular Carcinoma Following Direct-Acting Antivirals Therapy in a Prospective Genotype-3 Predominant HCV Elimination Compensated Cirrhosis Cohort. // Journal of Clinical and Experimental Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S0973688326001416?dgcid=rss_sd_all
Incidence, Predictors, and Course of Hepatocellular Carcinoma Following Direct-Acting Antivirals Therapy in a Prospective Genotype-3 Predominant HCV Elimination Compensated Cirrhosis Cohort. Journal of Clinical and Experimental Hepatology. https://www.sciencedirect.com/science/article/pii/S0973688326001416?dgcid=rss_sd_all
“Incidence, Predictors, and Course of Hepatocellular Carcinoma Following Direct-Acting Antivirals Therapy in a Prospective Genotype-3 Predominant HCV Elimination Compensated Cirrhosis Cohort.” Journal of Clinical and Experimental Hepatology.
@article{article89749,
title = {Incidence, Predictors, and Course of Hepatocellular Carcinoma Following Direct-Acting Antivirals Therapy in a Prospective Genotype-3 Predominant HCV Elimination Compensated Cirrhosis Cohort},
journal = {Journal of Clinical and Experimental Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S0973688326001416?dgcid=rss_sd_all}
}